US20170042661A1 - Vascular prosthesis - Google Patents
Vascular prosthesis Download PDFInfo
- Publication number
- US20170042661A1 US20170042661A1 US15/269,906 US201615269906A US2017042661A1 US 20170042661 A1 US20170042661 A1 US 20170042661A1 US 201615269906 A US201615269906 A US 201615269906A US 2017042661 A1 US2017042661 A1 US 2017042661A1
- Authority
- US
- United States
- Prior art keywords
- diameter
- tubular portion
- generally tubular
- vascular prosthesis
- prosthesis according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002792 vascular Effects 0.000 title claims abstract description 36
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 6
- 210000004204 blood vessel Anatomy 0.000 claims abstract 6
- 230000017531 blood circulation Effects 0.000 claims description 19
- 239000008280 blood Substances 0.000 claims description 17
- 210000004369 blood Anatomy 0.000 claims description 16
- 230000007704 transition Effects 0.000 claims description 15
- 230000001939 inductive effect Effects 0.000 claims description 4
- 210000001367 artery Anatomy 0.000 abstract description 28
- 206010020718 hyperplasia Diseases 0.000 description 9
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 8
- 239000004810 polytetrafluoroethylene Substances 0.000 description 8
- 230000003872 anastomosis Effects 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 238000000926 separation method Methods 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- -1 polytetrafluoroethylene Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004013 groin Anatomy 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003752 saphenous vein Anatomy 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/064—Blood vessels with special features to facilitate anastomotic coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/11—Surgical instruments, devices or methods for performing anastomosis; Buttons for anastomosis
- A61B2017/1135—End-to-side connections, e.g. T- or Y-connections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/008—Quadric-shaped paraboloidal
Definitions
- By-passes to save limbs may be required to have a relatively long length, such as the distance from the groin to below the knee, and may be required to attach to arteries that may be as small as 1 mm to 5 mm in diameter.
- arteries may be as small as 1 mm to 5 mm in diameter.
- prosthetic grafts of synthetic materials for example flexible tubes of polytetrafluoroethylene (PTFE).
- U.S. Pat. No. 5,156,619 discloses a vascular prosthesis comprising a tube of material other than autologous vascular tissue, the tube having an enlarged end formation for surgical connection direct to an opening formed in an artery, the formation having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter.
- WO 97/31591 discloses a flanged graft for end-to-side anastomosis grafting having an integral terminal flanged skirt or cuff, which facilitates an end-to-side anastomosis directly between an artery and the expanded flange bypass graft without need for an intervening venous collar or venous patch.
- a vascular prosthesis comprising a tube of synthetic material having an end formation for surgical connection directly to an opening formed in an artery, the end formation comprising an enlarged chamber serving to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to the arterial wall.
- the term “non-laminar” as used herein is intended to define blood flow other than parallel to arterial walls and, in particular, includes localized laminar movement of blood having significant secondary components.
- the proposed enlarged chamber has a convex outer wall. Further experimentation, however, has revealed that this type of vascular prosthesis, while representing an improvement on the aforementioned Miller cuff may still not be ideal for certain applications.
- an object of the present invention is to provide an improved vascular prosthesis for use in vascular surgery.
- a vascular prosthesis comprising a tube of material other than autologous vascular tissue, said tube having an end formation for surgical connection direct to an opening formed in an artery, said formation comprising an enlarged chamber having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter, characterized in that a transition between the tube and the toe is outwardly initially convex before a final concave portion, whereby said enlarged chamber serves to promote localized movement of blood having a non-laminar nature with shear stress inducing relationship to receiving arterial wall.
- the heel of the enlarged chamber is formed at one end of the longer diameter, and the transition between the tube and the heel is preferably generally concave. Transition between the tube and opposite ends of the shorter diameter is preferably outwardly convex. It is also preferable that the tube have a narrower portion prior to transition to the enlarged chamber. It is believed that such narrowing of the tube will increase blood velocity entering the enlarged chamber of the prosthesis and hence increase shear stress in that region.
- the grafts of the invention are preferably made of plastics material, especially polytetrafluoroethylene (PTFE).
- the vascular prosthesis of the invention is intended to promote vertical blood flow in the region of its arterial connection in order to reduce or eliminate regions of low shear stress and regions of long residence times where blood elements can accumulate in the region of the graft connection.
- Separation of flowing blood from the inner wall of the tube near its enlarged chamber, and associated with non-laminar flow, is preferably such as to produce a swirling action that may include locally circulatory or re-circulatory movement of blood, further preferably in the nature of or including a vortex action.
- Such blood flow separation will usually occur directly at, as well as adjacent to, preferred acute angling of the prosthesis tube for its direct connection to the artery, which would be at least partially within the enlarged chamber.
- a preferred end chamber of the prosthesis tube of the invention is an enlargement which produces blood flow characteristics therein that result in an increase in wall shear stress.
- Desired non-laminar-blood flow promotion is preferably effective only in phases of cycles of blood-flow pulsing, which phases preferably alternate with other phases of more laminar flow sufficient to assist flow of all blood into the artery away from that end of the prosthesis.
- the pulsed nature of normal blood flow involved successive time-spaced rises in pressure. Each pressure rise preferably causes both an initial relatively smooth or laminar blood flow in and out of the prosthesis-to-artery connection and a later transition into desired non-laminar blood movement.
- the preferred non-laminar vortex type movement preferably collapses before the next pressure rise.
- FIG. 1 is a sectional line diagram useful for explaining problems arising from simple direct connection or anastomoses of a prosthetic graft tube of synthetic material to an opening made in an artery.
- FIG. 2 shows use of a veinous cuff interposed between a prosthetic graft tube and an artery.
- FIG. 3 is a section through the graft of FIG. 2 showing typical blood flow therethrough.
- FIG. 4 is a side view of a first prosthetic graft of the invention.
- FIG. 5 is a rear view of the graft of FIG. 4 .
- FIG. 6 is a view from below of the graft of FIG. 4 .
- FIG. 7 is a perspective view of the graft of FIG. 4 .
- FIG. 8 shows the graft of FIGS. 4 to 7 connected to an artery.
- FIG. 9 is a side view of a second prosthetic graft of the invention.
- FIG. 10 is a rear view of the graft of FIG. 9 .
- FIG. 11 is a view from below of the graft of FIG. 9 .
- FIG. 12 is a perspective view of the graft of FIG. 9 .
- FIG. 13 shows the graft of FIGS. 9 to 12 .
- FIGS. 1-3 prior art devices are depicted in FIGS. 1-3 .
- artery 12 has an opening made by an incision at 16 .
- Prosthetic graft tube 10 of synthetic material (for which PTFE, most usually expanded PTFE (ePTFE), is widely used in practice) is run at an acute angle or more or less parallel to the artery 12 .
- Tube 10 is indicated cut to an angled end 18 that is end to edge sewn into the opening 16 .
- myointimal-hyperplasia to occur later in the receiving artery 12 (see indicated development of fibrous or scare-like tissue in the toe and heel positions 11 and 13 , respectively), and also at plate position 15 opposite the opening 16 .
- FIGS. 2 and 3 illustrate the Miller cuff, aimed at reducing such problems by using a short length of another vein, usually from still usable parts of the saphenous vein that would be used in its entirety if serviceable.
- This short length of autologous vein typically 2 to 3 mm in diameter, is removed and opened along its length, then sutured first to an opening 36 of the artery 32 and end-to-end to itself at 39 .
- the completed cuff 34 is trimmed and anastomoses completed at 38 to normally wider prosthetic graft tube 30 .
- the graft tube 30 is typically made of PTFE and is at least 4 mm, preferably 6 mm if not more, in diameter.
- FIG. 3 Typical blood flow through the Miller cuff is shown in FIG. 3 .
- a vortex 40 is formed to increase shear stress; however at opposite sides of the cuff, low shear stress regions 42 , 44 develop where accumulation of deposits can form, resulting in intimal hyperplasia. Furthermore, where flow separates at the arterial wall opposite the cuff, a low shear stress region 46 also develops where intimal hyperplasia is possible.
- a first vascular prosthetic graft 50 is ideally made of polytetrafluoroethylene.
- the graft has a tubular part 52 of any desired length according to the length of the by-pass to be made using the graft and an enlargement 54 at one or both ends of the tube 52 (only one is shown).
- the enlargement 54 has an open end of a generally oval cross-section forming a heel 56 and a toe 58 at opposite ends of the larger diameter of the open end.
- Sides 66 of the enlargement 54 at opposite ends of the shorter diameter of the open end are generally outwardly convex.
- the plane of the open end of the enlargement 54 and of the tube 52 are generally parallel but it should be noted that prosthetic grafts having different separations thereof may be made for use in different situations. It should be further noted that prosthetic grafts having open ends of varying longer diameters may be produced. Furthermore, the degree of curvature either to the heel or the toe may be varied from graft to graft, in order to alter blood flow characteristics through the graft connection.
- the prosthetic graft 50 is in practice connected to an artery by forming a slit in a side of an artery 67 , opening out the slit and stitching the open end of the graft to the sides of the slit.
- connection of the graft causes the artery to have a concave underside opposite the graft as can be seen at 68 in FIG. 8 of the drawings.
- the length of the open end of the graft will probably be in the order of 14 to 36 mm and the width of the open end is unlikely to be less than 6 mm and probably not greater than 14 mm.
- FIGS. 9 to 13 illustrate a variation on the prosthetic graft of the present embodiment. Like parts have been numbered similarly and only the main difference between them will now be described.
- the tube 52 of the graft includes a narrower portion 70 prior to commencement of the enlargement.
Landscapes
- Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
A vascular prosthesis configured for direct connection to an artery. The vascular prosthesis may include a tube of material other than autologous vascular tissue, having an end formation, which is configured for surgical connection to an opening formed in the artery, and a narrower portion prior to commencement of the end formation. The end formation may have an enlarged chamber adapted to induce a concave section in said blood vessel upon attachment thereto.
Description
- This application is a continuation of U.S. Patent Application Ser. No. 10/603,952, now U.S. Pat. No. 9,445,886, filed on Jun. 25, 2003, which is a continuation of U.S. Patent Application Ser. No. 09/762,761, now U.S. Pat. No. 6,589,278, filed Oct. 5, 2001, which is a 371 of International Application No. PCT/GB998/01418, filed May 15, 1998, claiming priority to United Kingdom patent application GB 9709967.5, filed May 17, 1997. This application expressly incorporates by reference the entirety of each of the above mentioned applications as if fully set forth herein.
- By-passes to save limbs may be required to have a relatively long length, such as the distance from the groin to below the knee, and may be required to attach to arteries that may be as small as 1 mm to 5 mm in diameter. Where patients have no other veins that can be used, as is often the case with patients having relevant serious conditions, the only positive alternative is to use prosthetic grafts of synthetic materials, for example flexible tubes of polytetrafluoroethylene (PTFE). Simple direct end connections or anastomosis of prosthetic graft tubes (usually run at an acute angle or more or less parallel with the artery and end cut at an angle) to side apertures in arteries, perhaps particularly arteries substantially less than 5 mm in diameter, has unfortunately been followed by formation of fibrous intimal hyperplasia, which leads to serious blood flow reduction and even stoppage. The fibrous intimal hyperplasia occurs in regions within and around the graft connection, where there is little or no shear stress between the blood flow and the graft and arterial walls.
- It is known to use a small piece of natural vein to make a short cuff known as the Miller cuff (that is joined by surgical stitching to and between the artery opening and the end of the prosthetic graft tube. Improved success rates for indirect prosthesis-to-vein-to-artery connection, compared with direct prosthesis-to-artery, have involved reduced adverse effect from intimal hyperplasia. Contributory factors, for cuff type and other prosthesis types, have been considered and postulated as including reducing tendencies to turbulence of blood flow, and/or optimizing approximation to laminar blood flow, and/or for suppleness of the natural vein parts to aid absorption or cushioning blood pulsing. These factors have further been seen particularly as contributing to avoiding or minimizing occurrence of artery wall shear stress. However, fibrous intimal hyperplasia still occurs with the so called Miller cuff because regions of flow separation and low shear stress still occur within the cuff.
- U.S. Pat. No. 5,156,619 discloses a vascular prosthesis comprising a tube of material other than autologous vascular tissue, the tube having an enlarged end formation for surgical connection direct to an opening formed in an artery, the formation having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter. WO 97/31591 discloses a flanged graft for end-to-side anastomosis grafting having an integral terminal flanged skirt or cuff, which facilitates an end-to-side anastomosis directly between an artery and the expanded flange bypass graft without need for an intervening venous collar or venous patch.
- It has been proposed to provide a vascular prosthesis comprising a tube of synthetic material having an end formation for surgical connection directly to an opening formed in an artery, the end formation comprising an enlarged chamber serving to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to the arterial wall. The term “non-laminar” as used herein is intended to define blood flow other than parallel to arterial walls and, in particular, includes localized laminar movement of blood having significant secondary components. The proposed enlarged chamber has a convex outer wall. Further experimentation, however, has revealed that this type of vascular prosthesis, while representing an improvement on the aforementioned Miller cuff may still not be ideal for certain applications.
- Therefore, it is an object of the present invention is to provide an improved vascular prosthesis for use in vascular surgery.
- According to the present' invention there is provided a vascular prosthesis comprising a tube of material other than autologous vascular tissue, said tube having an end formation for surgical connection direct to an opening formed in an artery, said formation comprising an enlarged chamber having a heel and a toe at opposite ends of a first longer diameter parallel to the axis of the tube and a second shorter transverse diameter, characterized in that a transition between the tube and the toe is outwardly initially convex before a final concave portion, whereby said enlarged chamber serves to promote localized movement of blood having a non-laminar nature with shear stress inducing relationship to receiving arterial wall.
- The heel of the enlarged chamber is formed at one end of the longer diameter, and the transition between the tube and the heel is preferably generally concave. Transition between the tube and opposite ends of the shorter diameter is preferably outwardly convex. It is also preferable that the tube have a narrower portion prior to transition to the enlarged chamber. It is believed that such narrowing of the tube will increase blood velocity entering the enlarged chamber of the prosthesis and hence increase shear stress in that region. The grafts of the invention are preferably made of plastics material, especially polytetrafluoroethylene (PTFE).
- The vascular prosthesis of the invention is intended to promote vertical blood flow in the region of its arterial connection in order to reduce or eliminate regions of low shear stress and regions of long residence times where blood elements can accumulate in the region of the graft connection. Separation of flowing blood from the inner wall of the tube near its enlarged chamber, and associated with non-laminar flow, is preferably such as to produce a swirling action that may include locally circulatory or re-circulatory movement of blood, further preferably in the nature of or including a vortex action. Such blood flow separation will usually occur directly at, as well as adjacent to, preferred acute angling of the prosthesis tube for its direct connection to the artery, which would be at least partially within the enlarged chamber. A preferred end chamber of the prosthesis tube of the invention is an enlargement which produces blood flow characteristics therein that result in an increase in wall shear stress.
- Desired non-laminar-blood flow promotion is preferably effective only in phases of cycles of blood-flow pulsing, which phases preferably alternate with other phases of more laminar flow sufficient to assist flow of all blood into the artery away from that end of the prosthesis. The pulsed nature of normal blood flow involved successive time-spaced rises in pressure. Each pressure rise preferably causes both an initial relatively smooth or laminar blood flow in and out of the prosthesis-to-artery connection and a later transition into desired non-laminar blood movement. The preferred non-laminar vortex type movement preferably collapses before the next pressure rise.
- These and other embodiments, features and advantages of the present invention will become more apparent to those skilled in the art when taken with reference to the following more detailed description of the invention in conjunction with the accompanying drawings that are first briefly described.
-
FIG. 1 is a sectional line diagram useful for explaining problems arising from simple direct connection or anastomoses of a prosthetic graft tube of synthetic material to an opening made in an artery. -
FIG. 2 shows use of a veinous cuff interposed between a prosthetic graft tube and an artery. -
FIG. 3 is a section through the graft ofFIG. 2 showing typical blood flow therethrough. -
FIG. 4 is a side view of a first prosthetic graft of the invention. -
FIG. 5 is a rear view of the graft ofFIG. 4 . -
FIG. 6 is a view from below of the graft ofFIG. 4 . -
FIG. 7 is a perspective view of the graft ofFIG. 4 . -
FIG. 8 shows the graft ofFIGS. 4 to 7 connected to an artery. -
FIG. 9 is a side view of a second prosthetic graft of the invention. -
FIG. 10 is a rear view of the graft ofFIG. 9 . -
FIG. 11 is a view from below of the graft ofFIG. 9 . -
FIG. 12 is a perspective view of the graft ofFIG. 9 . -
FIG. 13 shows the graft ofFIGS. 9 to 12 . - The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected preferred embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the intention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
- In the drawings, prior art devices are depicted in
FIGS. 1-3 . Referring first toFIG. 1 ,artery 12 has an opening made by an incision at 16.Prosthetic graft tube 10 of synthetic material (for which PTFE, most usually expanded PTFE (ePTFE), is widely used in practice) is run at an acute angle or more or less parallel to theartery 12. Tube 10 is indicated cut to anangled end 18 that is end to edge sewn into the opening 16. Unfortunately, there is a tendency for myointimal-hyperplasia to occur later in the receiving artery 12 (see indicated development of fibrous or scare-like tissue in the toe andheel positions plate position 15 opposite theopening 16. This development can seriously reduce the very blood flow that it is the object of the procedure to improve. Indeed, this condition all too often progresses to complete blockage of such blood flow. These problems are pronounced as the size of the receivingartery 12 decreases, which can be as small as 1 to 5 mm for the type of distal bypasses often needed, such as from the groin to beyond the knee as is frequently necessary to save a patient's lower leg. -
FIGS. 2 and 3 illustrate the Miller cuff, aimed at reducing such problems by using a short length of another vein, usually from still usable parts of the saphenous vein that would be used in its entirety if serviceable. This short length of autologous vein, typically 2 to 3 mm in diameter, is removed and opened along its length, then sutured first to anopening 36 of theartery 32 and end-to-end to itself at 39. The completedcuff 34 is trimmed and anastomoses completed at 38 to normally widerprosthetic graft tube 30. Thegraft tube 30 is typically made of PTFE and is at least 4 mm, preferably 6 mm if not more, in diameter. Improvement in terms of reducing development of intimal hyperplasia was originally, and has since consistently been, attributed to the autologous vein-to-artery junction. The suppleness of the veinous tissue may also have contributed to this improvement by assisting absorption of pressure pulsing and reducing shear wall stress in the receiving artery. Wall shear stress was assumed and reported as being the major causative factor in development of intimal hyperplasia. This procedure has become popular and has been the subject of considerable development, including similar use in interconnected small arteries. - Typical blood flow through the Miller cuff is shown in
FIG. 3 . Avortex 40 is formed to increase shear stress; however at opposite sides of the cuff, lowshear stress regions shear stress region 46 also develops where intimal hyperplasia is possible. - Turning to
FIGS. 4 to 8 of the accompanying drawings, a first vascularprosthetic graft 50 according to the invention is ideally made of polytetrafluoroethylene. The graft has atubular part 52 of any desired length according to the length of the by-pass to be made using the graft and anenlargement 54 at one or both ends of the tube 52 (only one is shown). Theenlargement 54 has an open end of a generally oval cross-section forming aheel 56 and atoe 58 at opposite ends of the larger diameter of the open end. There is a generally outwardlyconcave transition 60 between thetube 52 and theheel 56 and between thetube 52 and the toe 58 a firstly convex 62 and a final concave 64 transition.Sides 66 of theenlargement 54 at opposite ends of the shorter diameter of the open end are generally outwardly convex. - The plane of the open end of the
enlargement 54 and of thetube 52 are generally parallel but it should be noted that prosthetic grafts having different separations thereof may be made for use in different situations. It should be further noted that prosthetic grafts having open ends of varying longer diameters may be produced. Furthermore, the degree of curvature either to the heel or the toe may be varied from graft to graft, in order to alter blood flow characteristics through the graft connection. Theprosthetic graft 50 is in practice connected to an artery by forming a slit in a side of anartery 67, opening out the slit and stitching the open end of the graft to the sides of the slit. It is to be noted that such connection of the graft causes the artery to have a concave underside opposite the graft as can be seen at 68 inFIG. 8 of the drawings. The length of the open end of the graft will probably be in the order of 14 to 36 mm and the width of the open end is unlikely to be less than 6 mm and probably not greater than 14 mm. -
FIGS. 9 to 13 illustrate a variation on the prosthetic graft of the present embodiment. Like parts have been numbered similarly and only the main difference between them will now be described. In order to increase the velocity of blood flow through the graft connection to an artery, thetube 52 of the graft includes anarrower portion 70 prior to commencement of the enlargement. - The present invention has been described above in terms of certain preferred embodiments so that an understanding of the present invention can be conveyed. However, there are many alternative arrangements not specifically described herein but with which the present invention is applicable. Although specific features have been provided, the device of the present invention would equally be embodied by other configurations not specifically recited herein. The scope of the present invention should therefore not be limited by the embodiments illustrated, but rather it should be understood that the present invention has wide applicability with respect to vascular prostheses generally. All modifications, variations, or equivalent elements and implementations that are within the scope of the appended claims should therefore be considered within the scope of the invention.
Claims (20)
1. A vascular prosthesis comprising:
generally tubular portion that defines a blood-flow lumen and that has a luminal surface that contacts blood flowing through the lumen, and an abluminal surface that does not contact blood flowing through the lumen, wherein the luminal surface comprises a material other than vascular tissue,
wherein
the tubular portion has an end formation, the end formation comprising an enlarged chamber having a first diameter and a second diameter transverse to the axis of the generally tubular portion,
the first diameter is longer than the second diameter,
the first diameter comprising a heel and a toe,
a transition between the tubular portion the toe is outwardly initially convex before a final concave portion,
and
the enlarged chamber is adapted to induce a concave section in a blood vessel.
2. The vascular prosthesis according to claim 1 wherein the enlarged chamber is configured to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to a wall of the blood vessel.
3. The vascular prosthesis according to claim 2 wherein a transition between the generally tubular portion and the heel is generally outwardly concave.
4. The vascular prosthesis according to claim 3 wherein opposing sides of the second diameter are generally outwardly convex.
5. The vascular prosthesis according to claim 4 further comprising a narrow section positioned between the generally tubular portion and the end formation, wherein a diameter of the narrow section is less than a diameter of the generally tubular portion.
6. The vascular prosthesis according to claim 5 the generally tubular portion having a second end formation at an end of the generally tubular portion opposite the end formation.
7. The vascular prosthesis according to claim 6 wherein the second end formation comprises a second enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion, wherein the first diameter is longer than the second diameter, the first diameter comprising a heel and a toe, wherein a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion.
8. The vascular prosthesis according to claim 7 wherein a transition between the generally tubular portion and the heel of the second enlarged chamber is generally outwardly concave.
9. The vascular prosthesis according to claim 8 wherein opposing sides of the second diameter of the second enlarged chamber are generally outwardly convex.
10. The vascular prosthesis according to claim 9 further comprising a second narrow section positioned between the generally tubular portion and the second end formation, wherein a diameter of the second narrow section is less than a diameter of the generally tubular portion.
11. A vascular prosthesis comprising:
generally tubular portion that defines a blood-flow lumen and that has a luminal surface that contacts blood flowing through the lumen, and an abluminal surface that does not contact blood flowing through the lumen, wherein the luminal surface comprises a material other than vascular tissue,
wherein
the tubular portion has an end formation configured for surgical connection to an opening formed in a blood vessel, the end formation comprising an enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion,
the first diameter is longer than the second diameter,
the first diameter comprising a heel and a toe,
a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion,
and
the enlarged chamber is adapted to induce a concave section in the blood vessel upon attachment of the prosthesis to the vessel.
12. The vascular prosthesis according to claim 11 wherein the enlarged chamber is configured to promote localized movement of blood having a non-laminar nature with a shear stress inducing relationship to a wall of the blood vessel.
13. The vascular prosthesis according to claim 12 wherein a transition between the generally tubular portion and the heel is generally outwardly concave.
14. The vascular prosthesis according to claim 13 wherein opposing sides of the second diameter are generally outwardly convex.
15. The vascular prosthesis according to claim 14 further comprising a narrow section positioned between the generally tubular portion and the end formation, wherein a diameter of the narrow section is less than a diameter of the generally tubular portion.
16. The vascular prosthesis according to claim 15 the generally tubular portion having a second end formation at an end of the generally tubular portion opposite the end formation.
17. The vascular prosthesis according to claim 16 wherein the second end formation comprises a second enlarged chamber having a first diameter parallel to the axis of the generally tubular portion and a second diameter transverse to the axis of the generally tubular portion, wherein the first diameter is longer than the second diameter, the first diameter comprising a heel and a toe, wherein a transition between the generally tubular portion and the toe is outwardly initially convex before a final concave portion.
18. The vascular prosthesis according to claim 17 wherein a transition between the generally tubular portion and the heel of the second enlarged chamber is generally outwardly concave.
19. The vascular prosthesis according to claim 18 wherein opposing sides of the second diameter of the second enlarged chamber are generally outwardly convex.
20. The vascular prosthesis according to claim 19 further comprising a second narrow section positioned between the generally tubular portion and the second end formation, wherein a diameter of the second narrow section is less than a diameter of the generally tubular portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/269,906 US20170042661A1 (en) | 1997-05-17 | 2016-09-19 | Vascular prosthesis |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9709967.5A GB9709967D0 (en) | 1997-05-17 | 1997-05-17 | Prosthetic grafts |
GB9709967.5 | 1997-05-17 | ||
PCT/GB1998/001418 WO1998052495A1 (en) | 1997-05-17 | 1998-05-15 | Vascular prosthesis |
US09/762,761 US6589278B1 (en) | 1997-05-17 | 1998-05-15 | Vascular prosthesis |
US10/603,952 US9445886B2 (en) | 1997-05-17 | 2003-06-25 | Vascular prosthesis |
US15/269,906 US20170042661A1 (en) | 1997-05-17 | 2016-09-19 | Vascular prosthesis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/603,952 Continuation US9445886B2 (en) | 1997-05-17 | 2003-06-25 | Vascular prosthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170042661A1 true US20170042661A1 (en) | 2017-02-16 |
Family
ID=10812426
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/762,761 Expired - Lifetime US6589278B1 (en) | 1997-05-17 | 1998-05-15 | Vascular prosthesis |
US10/603,952 Expired - Fee Related US9445886B2 (en) | 1997-05-17 | 2003-06-25 | Vascular prosthesis |
US15/269,906 Abandoned US20170042661A1 (en) | 1997-05-17 | 2016-09-19 | Vascular prosthesis |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/762,761 Expired - Lifetime US6589278B1 (en) | 1997-05-17 | 1998-05-15 | Vascular prosthesis |
US10/603,952 Expired - Fee Related US9445886B2 (en) | 1997-05-17 | 2003-06-25 | Vascular prosthesis |
Country Status (10)
Country | Link |
---|---|
US (3) | US6589278B1 (en) |
EP (1) | EP1011533B1 (en) |
JP (1) | JP4280308B2 (en) |
AT (1) | ATE367127T1 (en) |
AU (1) | AU7441998A (en) |
CA (1) | CA2303802C (en) |
DE (1) | DE69838100T2 (en) |
ES (1) | ES2288763T3 (en) |
GB (1) | GB9709967D0 (en) |
WO (1) | WO1998052495A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019220322A1 (en) | 2018-05-14 | 2019-11-21 | Sabic Global Technologies B.V. | Hydrogen production from aqueous formaldehyde under mild basic conditions |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6273912B1 (en) | 1996-02-28 | 2001-08-14 | Impra, Inc. | Flanged graft for end-to-side anastomosis |
AU723247B2 (en) * | 1996-02-28 | 2000-08-24 | Bard Peripheral Vascular, Inc. | Flanged graft for end-to-side anastomosis |
GB9709967D0 (en) * | 1997-05-17 | 1997-07-09 | Harris Peter L | Prosthetic grafts |
US9814869B1 (en) * | 1999-06-15 | 2017-11-14 | C.R. Bard, Inc. | Graft-catheter vascular access system |
US6821295B1 (en) * | 2000-06-26 | 2004-11-23 | Thoratec Corporation | Flared coronary artery bypass grafts |
JP3673744B2 (en) * | 2001-09-27 | 2005-07-20 | 大晃機械工業株式会社 | Vacuum pump |
FR2850008A1 (en) * | 2003-01-17 | 2004-07-23 | Daniel Roux | Vascular prosthesis has tube and collar for adapting to blood vessel ends of different diameters |
US7998188B2 (en) * | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
WO2006013234A1 (en) * | 2004-07-02 | 2006-02-09 | Daniel Roux | Vascular prosthesis for adapting diameter differences between two ends of a replaceable blood vessel segment |
JP4964134B2 (en) | 2004-08-31 | 2012-06-27 | シー・アール・バード・インコーポレーテッド | Self-sealing PTFE graft with torsion resistance |
WO2006044904A2 (en) * | 2004-10-15 | 2006-04-27 | Vanderbilt University | Nano- and micro-scale engineering of polymeric scaffolds for vascular tissue engineering |
US20110076315A1 (en) * | 2005-06-08 | 2011-03-31 | C.R Bard, Inc. | Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt |
ES2625807T3 (en) | 2005-06-17 | 2017-07-20 | C.R. Bard, Inc. | Vascular graft with twisting resistance after clamping |
US8709069B2 (en) * | 2005-07-01 | 2014-04-29 | C. R. Bard, Inc. | Flanged graft with trim lines |
CA2626598A1 (en) | 2005-11-09 | 2007-05-18 | C.R. Bard Inc. | Grafts and stent grafts having a radiopaque marker |
US7722665B2 (en) | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
DE102006036073A1 (en) * | 2006-08-02 | 2008-02-07 | Heise, Michael, Dr.med. | Vascular tubular graft |
EP2079575B1 (en) | 2006-10-12 | 2021-06-02 | C.R. Bard, Inc. | Methods for making vascular grafts with multiple channels |
US9039758B2 (en) * | 2006-12-07 | 2015-05-26 | Stanley Batiste | Bypass vascular graft |
US9603695B2 (en) | 2006-12-07 | 2017-03-28 | Stanley Batiste | Bypass vascular graft |
US9549808B2 (en) | 2006-12-07 | 2017-01-24 | Stanley Batiste | Bypass configuration and method of construction |
US20130197546A1 (en) | 2007-08-02 | 2013-08-01 | Bioconnect Systems, Inc. | Implantable flow connector |
US8690816B2 (en) | 2007-08-02 | 2014-04-08 | Bioconnect Systems, Inc. | Implantable flow connector |
DE102007063265A1 (en) * | 2007-12-17 | 2009-06-18 | Aesculap Ag | Woven textile vascular prosthesis |
US20100121247A1 (en) * | 2008-11-13 | 2010-05-13 | Chen Yang | Dialysis Graft with Thromboses Prevention Arrangement |
US20120071965A1 (en) * | 2010-09-17 | 2012-03-22 | Longo Michael A | Implantable graft connector |
US10434293B2 (en) | 2012-04-15 | 2019-10-08 | Tva Medical, Inc. | Implantable flow connector |
US9314600B2 (en) | 2012-04-15 | 2016-04-19 | Bioconnect Systems, Inc. | Delivery system for implantable flow connector |
CA2891620C (en) | 2012-08-10 | 2021-05-25 | Abiomed, Inc. | Graft anchor devices, systems, and methods |
US9814563B1 (en) * | 2014-04-25 | 2017-11-14 | David M. Hoganson | Hemodynamically optimized shunt |
US20160007997A1 (en) * | 2014-07-14 | 2016-01-14 | Chengxiong Gu | Bridge vessels-proximal anastomosis supporting device for coronary artery bypass grafting and manufacturing method thereof |
CN111417361B (en) | 2017-12-01 | 2023-08-11 | C·R·巴德股份有限公司 | Adjustable vascular grafts for customized inside diameter reduction and related methods |
US11974748B2 (en) | 2019-01-11 | 2024-05-07 | The Regents Of The University Of Colorado | System and method for attaching a fluid conduit to an anatomical structure |
EP4507624A1 (en) | 2022-03-23 | 2025-02-19 | Connex Biomedical, Inc. | Assembly for end-to-side anastamosis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530113A (en) * | 1983-05-20 | 1985-07-23 | Intervascular, Inc. | Vascular grafts with cross-weave patterns |
Family Cites Families (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2127903A (en) | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
US3196194A (en) | 1964-06-04 | 1965-07-20 | Pennsylvania Fluorocarbon Co I | Fep-fluorocarbon tubing process |
US3492994A (en) | 1967-08-25 | 1970-02-03 | Joseph H Field | Nerve holder and guide for perpendicular cutting |
US3683926A (en) | 1970-07-09 | 1972-08-15 | Dainippon Pharmaceutical Co | Tube for connecting blood vessels |
US3713441A (en) | 1970-10-22 | 1973-01-30 | Battelle Development Corp | Method of using an artery vein shunt applique |
US3853462A (en) | 1972-02-23 | 1974-12-10 | Meadox Medicals Inc | Compaction of polyester fabric materials |
US3815608A (en) | 1972-03-10 | 1974-06-11 | East West Med Prod | Retaining catheter |
US3945052A (en) | 1972-05-01 | 1976-03-23 | Meadox Medicals, Inc. | Synthetic vascular graft and method for manufacturing the same |
US3816919A (en) | 1972-06-28 | 1974-06-18 | H Portnoy | Means for cutting nerve tissue |
US3826257A (en) | 1972-07-14 | 1974-07-30 | T Buselmeier | Prosthetic shunt |
US3805301A (en) | 1972-07-28 | 1974-04-23 | Meadox Medicals Inc | Tubular grafts having indicia thereon |
US3818511A (en) | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
US3825257A (en) | 1973-10-19 | 1974-07-23 | G Palmer | Apparatus for practicing basketball throws |
US3882862A (en) | 1974-01-11 | 1975-05-13 | Olga Berend | Arteriovenous shunt |
US3986828A (en) | 1974-03-05 | 1976-10-19 | Meadox Medicals, Inc. | Polymer fabric compacting process |
US6436135B1 (en) | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
SU571253A1 (en) * | 1975-07-11 | 1977-09-05 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Apparatus fir suturing vessels with metal clips |
JPS5230097A (en) | 1975-09-02 | 1977-03-07 | Kaneyasu Miyata | Method of mounting different substitute blood vessel |
US4047252A (en) | 1976-01-29 | 1977-09-13 | Meadox Medicals, Inc. | Double-velour synthetic vascular graft |
US4234535A (en) | 1976-04-29 | 1980-11-18 | Sumitomo Electric Industries, Ltd. | Process for producing porous polytetrafluoroethylene tubings |
US4279259A (en) | 1976-07-06 | 1981-07-21 | Dow Corning Corporation | Mammometer |
US4192312A (en) | 1978-09-01 | 1980-03-11 | Wilson Donald L | Surgical incision guide means |
EP0011437B1 (en) | 1978-11-20 | 1983-06-22 | Imperial Chemical Industries Plc | A process for setting a product comprising electrostatically spun fibres, and products prepared according to this process |
US4321914A (en) | 1980-04-22 | 1982-03-30 | W. L. Gore & Associates, Inc. | Percutaneous conduit having PTFE skirt |
US4309776A (en) | 1980-05-13 | 1982-01-12 | Ramon Berguer | Intravascular implantation device and method of using the same |
JPS6028434Y2 (en) | 1980-06-16 | 1985-08-28 | 建部 容保 | Artificial blood vessel |
US4354495A (en) | 1980-10-30 | 1982-10-19 | Sherwood Medical Industries Inc. | Method of connecting plastic tube to a plastic part |
US4366819A (en) * | 1980-11-17 | 1983-01-04 | Kaster Robert L | Anastomotic fitting |
US4441215A (en) * | 1980-11-17 | 1984-04-10 | Kaster Robert L | Vascular graft |
US4387516A (en) | 1980-12-22 | 1983-06-14 | L & A, Inc. | Universal insole |
US4416028A (en) | 1981-01-22 | 1983-11-22 | Ingvar Eriksson | Blood vessel prosthesis |
US4503568A (en) * | 1981-11-25 | 1985-03-12 | New England Deaconess Hospital | Small diameter vascular bypass and method |
US4501263A (en) | 1982-03-31 | 1985-02-26 | Harbuck Stanley C | Method for reducing hypertension of a liver |
US4482516A (en) | 1982-09-10 | 1984-11-13 | W. L. Gore & Associates, Inc. | Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure |
US4517687A (en) | 1982-09-15 | 1985-05-21 | Meadox Medicals, Inc. | Synthetic woven double-velour graft |
IT1156682B (en) | 1982-10-14 | 1987-02-04 | Pro Bio Spe Produz Biolog Spec | LOW PROFILE BICUSPID ORGANIC VALVE |
US4546499A (en) | 1982-12-13 | 1985-10-15 | Possis Medical, Inc. | Method of supplying blood to blood receiving vessels |
US4909979A (en) | 1983-03-24 | 1990-03-20 | Possis Medical, Inc. | Method for making a vascular graft |
US4728328A (en) | 1984-10-19 | 1988-03-01 | Research Corporation | Cuffed tubular organic prostheses |
US4630375A (en) | 1985-05-02 | 1986-12-23 | Spolyar John L | Apparatus for gauging and determining spatial coordinates for a source of radiation to be employed in obtaining a radiograph of a patient |
US4807622A (en) | 1985-09-20 | 1989-02-28 | Kato Hatsujo Kaisha, Ltd. | Tube cutting and separating implement for conduit of blood or the like |
US5042161A (en) | 1985-10-07 | 1991-08-27 | Joseph Hodge | Intravascular sizing method and apparatus |
US4712551A (en) * | 1986-10-14 | 1987-12-15 | Rayhanabad Simon B | Vascular shunt |
GB8625679D0 (en) | 1986-10-27 | 1986-11-26 | Ethicon Inc | Synthetic vascular grafts |
JPH0763489B2 (en) | 1986-10-31 | 1995-07-12 | 宇部興産株式会社 | Medical tube |
US4743480A (en) | 1986-11-13 | 1988-05-10 | W. L. Gore & Associates, Inc. | Apparatus and method for extruding and expanding polytetrafluoroethylene tubing and the products produced thereby |
US4714421A (en) | 1987-02-11 | 1987-12-22 | National Tool & Manufacturing Co., Inc. | Quick-switch mold set with clamp means |
US4816028A (en) | 1987-07-01 | 1989-03-28 | Indu Kapadia | Woven vascular graft |
US4935190A (en) | 1987-07-10 | 1990-06-19 | William G. Whitney | Method of making balloon retention catheter |
US4840940A (en) | 1987-10-21 | 1989-06-20 | Sottiurai Vikrom S | Method for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin |
US4872455A (en) | 1987-11-25 | 1989-10-10 | Corvita Corporation | Anastomosis trimming device and method of using the same |
US5110526A (en) | 1988-09-22 | 1992-05-05 | Nippon Valqua Industries, Ltd. | Process for producing molded articles of polytetrafluoroethylene resin |
US4944737A (en) | 1988-12-14 | 1990-07-31 | Kathryn Rowe Bloom | Surgical stencil and method of using the same |
US4957669A (en) | 1989-04-06 | 1990-09-18 | Shiley, Inc. | Method for producing tubing useful as a tapered vascular graft prosthesis |
JP2678945B2 (en) | 1989-04-17 | 1997-11-19 | 有限会社ナイセム | Artificial blood vessel, method for producing the same, and substrate for artificial blood vessel |
US5100422A (en) | 1989-05-26 | 1992-03-31 | Impra, Inc. | Blood vessel patch |
DK0474748T3 (en) * | 1989-05-31 | 1995-05-01 | Baxter Int | Biological flap prosthesis |
US5571169A (en) | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
US5156619A (en) | 1990-06-15 | 1992-10-20 | Ehrenfeld William K | Flanged end-to-side vascular graft |
US5078735A (en) | 1990-06-18 | 1992-01-07 | Mobin Uddin Kazi | Prosthetic grafting method for bypass surgery |
DE69210225T2 (en) | 1991-02-14 | 1996-12-05 | Baxter Int | Manufacturing process for flexible biological tissue transplant materials |
US5304220A (en) | 1991-07-03 | 1994-04-19 | Maginot Thomas J | Method and apparatus for implanting a graft prosthesis in the body of a patient |
US5456714A (en) * | 1991-07-04 | 1995-10-10 | Owen; Earl R. | Tubular surgical implant having a locking ring and flange |
JPH05192408A (en) | 1991-09-06 | 1993-08-03 | C R Bard Inc | Production of expansion balloon |
FR2685208B1 (en) | 1991-12-23 | 1998-02-27 | Ela Medical Sa | VENTRICULAR CANNULA DEVICE. |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
DE4222380A1 (en) | 1992-07-08 | 1994-01-13 | Ernst Peter Prof Dr M Strecker | Endoprosthesis implantable percutaneously in a patient's body |
USD348618S (en) | 1992-08-21 | 1994-07-12 | Leslie Nan S | Breast examination pad |
CA2106523A1 (en) | 1992-10-06 | 1994-04-07 | Jude S. Sauer | Surgical device to prepare body tissue for anastomosis |
US5399352A (en) | 1993-04-14 | 1995-03-21 | Emory University | Device for local drug delivery and methods for using the same |
WO1995009585A1 (en) * | 1993-10-01 | 1995-04-13 | Imperial College Of Science, Technology & Medicine | Vascular prostheses |
US5443497A (en) | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
US5562617A (en) | 1994-01-18 | 1996-10-08 | Finch, Jr.; Charles D. | Implantable vascular device |
US5476506A (en) * | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
EP0766539B1 (en) * | 1994-06-13 | 2003-05-21 | Endomed, Inc. | Expandable endovascular graft and method for forming the same |
EP1582181A3 (en) | 1994-06-27 | 2010-04-21 | Bard Peripheral Vascular, Inc. | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith |
US5575817A (en) | 1994-08-19 | 1996-11-19 | Martin; Eric C. | Aorto femoral bifurcation graft and method of implantation |
US5653743A (en) * | 1994-09-09 | 1997-08-05 | Martin; Eric C. | Hypogastric artery bifurcation graft and method of implantation |
EP0782497B1 (en) | 1994-09-23 | 2001-07-11 | Impra, Inc. | Vascular graft containing carbon and method for making same |
IT1267463B1 (en) * | 1994-09-27 | 1997-02-05 | Alessandro Verona | PROSTHETIC DUCT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR PATHOLOGIES. |
US5472404A (en) | 1995-02-21 | 1995-12-05 | Volgushev; Valentin E. | Method for surgical correction of vascular occlusions |
US5695504A (en) | 1995-02-24 | 1997-12-09 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
US5976159A (en) | 1995-02-24 | 1999-11-02 | Heartport, Inc. | Surgical clips and methods for tissue approximation |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
US5591203A (en) | 1995-03-24 | 1997-01-07 | Organ, Inc. | Anastomosis cuff manipulator tool |
GB9510967D0 (en) | 1995-05-31 | 1995-07-26 | Harris Peter L | Vascular prostheses |
US5723005A (en) | 1995-06-07 | 1998-03-03 | Herrick Family Limited Partnership | Punctum plug having a collapsible flared section and method |
US5752934A (en) | 1995-09-18 | 1998-05-19 | W. L. Gore & Associates, Inc. | Balloon catheter device |
US6287315B1 (en) | 1995-10-30 | 2001-09-11 | World Medical Manufacturing Corporation | Apparatus for delivering an endoluminal prosthesis |
JP2750569B2 (en) * | 1995-12-07 | 1998-05-13 | 幸夫 堀口 | Intravascular blood flow regulator and artificial blood vessel for bypass |
US5843158A (en) | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US6190590B1 (en) | 1996-02-28 | 2001-02-20 | Impra, Inc. | Apparatus and method for making flanged graft for end-to-side anastomosis |
US6273912B1 (en) | 1996-02-28 | 2001-08-14 | Impra, Inc. | Flanged graft for end-to-side anastomosis |
AU723247B2 (en) | 1996-02-28 | 2000-08-24 | Bard Peripheral Vascular, Inc. | Flanged graft for end-to-side anastomosis |
US5849036A (en) * | 1996-03-29 | 1998-12-15 | Zarate; Alfredo R. | Vascular graft prosthesis |
SE509388C2 (en) | 1996-05-17 | 1999-01-18 | Jan Otto Solem | Branching device for a blood vessel |
US5824010A (en) | 1996-05-23 | 1998-10-20 | Mcdonald; Garth R. | Suture needle guide |
US5800514A (en) | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
FR2751867B1 (en) | 1996-08-05 | 1999-05-21 | Leriche Rene Ass | PROSTHESIS COLLERETTE |
US5782916A (en) * | 1996-08-13 | 1998-07-21 | Galt Laboratories, Inc. | Device for maintaining urinary continence |
US6019788A (en) | 1996-11-08 | 2000-02-01 | Gore Enterprise Holdings, Inc. | Vascular shunt graft and junction for same |
US6074419A (en) | 1996-12-31 | 2000-06-13 | St. Jude Medical, Inc. | Indicia for prosthetic device |
US6203735B1 (en) | 1997-02-03 | 2001-03-20 | Impra, Inc. | Method of making expanded polytetrafluoroethylene products |
US6102884A (en) | 1997-02-07 | 2000-08-15 | Squitieri; Rafael | Squitieri hemodialysis and vascular access systems |
US6302908B1 (en) * | 1997-03-24 | 2001-10-16 | Juan Carlos Parodi | Arterial graft device and method of positioning the same |
GB9709967D0 (en) | 1997-05-17 | 1997-07-09 | Harris Peter L | Prosthetic grafts |
GB9710905D0 (en) | 1997-05-27 | 1997-07-23 | Imperial College | Stent for blood vessel |
US5950320A (en) | 1997-08-29 | 1999-09-14 | Dorsey; Thomas R. | Medico-scientific measuring device |
US6187033B1 (en) | 1997-09-04 | 2001-02-13 | Meadox Medicals, Inc. | Aortic arch prosthetic graft |
US6019768A (en) * | 1997-11-18 | 2000-02-01 | Ethicon, Inc, | Suture anchor retriever and method for retrieving an implanted suture anchor |
US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
US6048362A (en) | 1998-01-12 | 2000-04-11 | St. Jude Medical Cardiovascular Group, Inc. | Fluoroscopically-visible flexible graft structures |
US5989287A (en) | 1998-05-06 | 1999-11-23 | Av Healing Llc | Vascular graft assemblies and methods for implanting same |
SE517169C2 (en) | 1998-10-23 | 2002-04-23 | Prisell Ab P | Template and punch to indicate as well as remove a piece of skin |
US6086553A (en) | 1999-07-01 | 2000-07-11 | Akbik; Mohamad J. | Arteriovenous shunt |
US6821295B1 (en) | 2000-06-26 | 2004-11-23 | Thoratec Corporation | Flared coronary artery bypass grafts |
US6585762B1 (en) | 2000-08-10 | 2003-07-01 | Paul Stanish | Arteriovenous grafts and methods of implanting the same |
US6458155B1 (en) | 2000-09-01 | 2002-10-01 | Edwards Lifesciences Corporation | Fresh donor heart valve sizer and method of use |
JP2004529735A (en) | 2001-06-18 | 2004-09-30 | イーバ コーポレイション | Prosthetic implants and their use |
US6858035B2 (en) | 2001-07-05 | 2005-02-22 | Converge Medical, Inc. | Distal anastomosis system |
US20030014108A1 (en) | 2001-07-16 | 2003-01-16 | Lauren Janice Hansen | Adjustable areola and nipple prosethesis |
US7407480B2 (en) | 2001-07-27 | 2008-08-05 | Ams Research Corporation | Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele |
US20030051362A1 (en) | 2001-09-14 | 2003-03-20 | Buckman Robert F. | Incision template and methods for use |
US20030182815A1 (en) | 2002-03-28 | 2003-10-02 | Kimberly-Clark Worldwide, Inc. | Surgical site marking system |
US7160320B2 (en) | 2002-04-16 | 2007-01-09 | The International Heart Institute Of Montana Foundation | Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support |
USD496596S1 (en) | 2003-04-30 | 2004-09-28 | Robert Dalrymple | Image french measuring adjunct |
ITBO20030631A1 (en) | 2003-10-23 | 2005-04-24 | Roberto Erminio Parravicini | VALVULAR PROSTHETIC EQUIPMENT, IN PARTICULAR FOR HEART APPLICATIONS. |
US7989490B2 (en) | 2004-06-02 | 2011-08-02 | Cordis Corporation | Injectable formulations of taxanes for cad treatment |
CA2600711C (en) | 2005-03-15 | 2014-07-08 | Surmodics, Inc. | Compliant polymeric coatings for insertable medical articles |
US8709069B2 (en) | 2005-07-01 | 2014-04-29 | C. R. Bard, Inc. | Flanged graft with trim lines |
WO2009086458A1 (en) | 2007-12-27 | 2009-07-09 | C.R. Bard. Inc. | Vascular graft prosthesis having a reinforced margin for enhanced anastomosis |
-
1997
- 1997-05-17 GB GBGB9709967.5A patent/GB9709967D0/en active Pending
-
1998
- 1998-05-15 WO PCT/GB1998/001418 patent/WO1998052495A1/en active IP Right Grant
- 1998-05-15 EP EP98921634A patent/EP1011533B1/en not_active Expired - Lifetime
- 1998-05-15 AT AT98921634T patent/ATE367127T1/en not_active IP Right Cessation
- 1998-05-15 CA CA002303802A patent/CA2303802C/en not_active Expired - Lifetime
- 1998-05-15 AU AU74419/98A patent/AU7441998A/en not_active Abandoned
- 1998-05-15 JP JP55010298A patent/JP4280308B2/en not_active Expired - Lifetime
- 1998-05-15 DE DE69838100T patent/DE69838100T2/en not_active Expired - Lifetime
- 1998-05-15 US US09/762,761 patent/US6589278B1/en not_active Expired - Lifetime
- 1998-05-15 ES ES98921634T patent/ES2288763T3/en not_active Expired - Lifetime
-
2003
- 2003-06-25 US US10/603,952 patent/US9445886B2/en not_active Expired - Fee Related
-
2016
- 2016-09-19 US US15/269,906 patent/US20170042661A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4530113A (en) * | 1983-05-20 | 1985-07-23 | Intervascular, Inc. | Vascular grafts with cross-weave patterns |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019220322A1 (en) | 2018-05-14 | 2019-11-21 | Sabic Global Technologies B.V. | Hydrogen production from aqueous formaldehyde under mild basic conditions |
Also Published As
Publication number | Publication date |
---|---|
US6589278B1 (en) | 2003-07-08 |
ATE367127T1 (en) | 2007-08-15 |
EP1011533A1 (en) | 2000-06-28 |
DE69838100D1 (en) | 2007-08-30 |
US9445886B2 (en) | 2016-09-20 |
GB9709967D0 (en) | 1997-07-09 |
AU7441998A (en) | 1998-12-11 |
CA2303802C (en) | 2007-04-03 |
ES2288763T3 (en) | 2008-01-16 |
JP4280308B2 (en) | 2009-06-17 |
CA2303802A1 (en) | 1998-11-26 |
DE69838100T2 (en) | 2008-04-10 |
EP1011533B1 (en) | 2007-07-18 |
US20040064181A1 (en) | 2004-04-01 |
JP2002510221A (en) | 2002-04-02 |
WO1998052495A1 (en) | 1998-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20170042661A1 (en) | Vascular prosthesis | |
JP3506253B2 (en) | Percutaneous prosthetic joint | |
US6221101B1 (en) | Controlled vortex inducing vascular prosthesis | |
US10182902B2 (en) | Differential dilation stent and method of use | |
US5989287A (en) | Vascular graft assemblies and methods for implanting same | |
US6306164B1 (en) | Short body endoprosthesis | |
EP1791497B1 (en) | Side branch stent graft | |
US20220039938A1 (en) | Flow modification devices in body lumens | |
US7651526B2 (en) | Vascular graft | |
US6315752B1 (en) | Implantable bypass device | |
US20060229710A1 (en) | Vascular graft | |
MXPA99010589A (en) | Vascular prosthesis | |
Seth et al. | Revascularization of a thrombosed, previously stented aorto‐renal graft using combined directional atherectomy and AngioJet thrombectomy | |
IE20040465A1 (en) | A vascular graft | |
Hallock | Vein coupler to simplify the end-to-side microanastomosis | |
Hans | Salvage of apparently occluded femoropopliteal autogenous vein graft (case report) | |
IE20060230A1 (en) | A vascular graft | |
MXPA99006482A (en) | Luminal endoprosthesis for ramification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |